environmental exposure but genetic, hormonal, and reproductive factors may all contribute to developing RA. RA affects 1% to 2% of adults and, like most autoimmune diseases, develops most often in women, with a female/male ratio of 3:1.
2) Previous report reviewed that hormonal involvement is the higher incidence in female RA patients, because disease symptoms lessen during pregnancy and exacerbate in the postpartal period. 3) Evidence for endocrine involvement in RA tissue and cells include presence of androgen and estrogen receptors, high concentrations of biologically active steroids, key enzymes of steroid metabolism, and significant changes of estrogen to androgen ratio. These data suggest that individual immune cells, including synovial macrophages, may behave as steroid-sensitive cells. 4) Previous studies showed that the immunomodulatory effects of androgens and estrogens may be mediated indirectly. 5) One of the best-characterized targets for feedback actions of gonadal steroids is the hypothalamic hormone gonadotrophin-releasing hormone (GnRH).
GnRH is a peptide synthesized and released by the hypothalamus that is responsible for the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) from the anterior pituitary.
GnRH1 gene located on chromosome 8 p21-11.2 synthesizes precursor GnRH1 protein of 92 amino acids, which is processed to GnRH1 decapeptide in mammals. 6) The gonadotroph cells in the anterior pituitary are bathed with pulsatile GnRH which then stimulates its own receptor (GnRHR) to cause secretion of LH and FSH. In females, the acute rise of LH during the LH surge, brought about by the process of GnRH-self priming, triggers ovulation.
7)
GnRH itself has been shown to be immunostimulatory. Immune cells produce bioactive GnRH and express receptors for GnRH. [8] [9] [10] [11] Previous studies showed that GnRH exerts stimulatory influences on expression of the interleukin-2 receptor, on B and T lymphocyte proliferation, and on serum IgG levels. 12, 13) Based on those data, it was hypothesized that differences in responsiveness to GnRH might be due to gender differences in expression of GnRH receptor or due to gender differences in expression of G proteins.
13)
We examined five single nucleotide polymorphisms and haplotypes in the GnRH1 regions and their association with susceptibility and severity with RA in female Korean patients.
Materials and Methods

Subjects
A total of 153 unrelated Korean female RA patients were participated (Table 1) 
Genotyping
Genomic DNA was extracted from whole blood cells using a NucleoSpin ® Blood kit (Macherey-Nagel, Easton, PA, USA). Five polymor phisms of a GnRH1 gene were selected (Fig. 1 
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AmpliTaq Gold DNA polymerase which was included in Taqman 
Statistics
For theses association study, Hardy-Weinberg equilibrium (HWE)
for all SNPs was assessed using SNPstats (http://bioinfo.iconcologia.net/index.php). 15) A linkage disequilibrium (LD) block of polymorphisms was tested using Haploview (version 4.0).
16)
The haplotypes and their frequencies were calculated by the EM algorithm. 17) Multiple logistic regression models were calculated for the odds ratio (OR), 95% confidence interval (CI) and corresponding p-values, controlling for age as covariables. For all statistical tests, A p-value of p＜0.05 was taken as significant.
Results
Clinical characteristics of RA in the female Korean
Clinical characteristics of RA patients and control subjects are shown in Table 2 
Association between GnRH1 polymorphisms and RA
To assess whether polymorphisms of GnRH1 have any correlation with the risk of rheumatoid arthritis, genotype frequencies of 5
SNPs (rs2659590, rs2321248, rs6186, rs6185 and rs2321049) were examined in 153 rheumatoid arthritis and 96 control subjects, and multiple logistic regression analysis with adjustment for age was done.
Genotype distributions of 5 polymorphisms in this study were in
Hardy-Weinberg equilibrium (p＞0.05 data not shown). Genotype distributions and allele frequency of 5 SNPs in RA and control subjects are revealed in Table 2 (Table 3) . Among 5 SNPs, rs6186
was monomorphic SNP. There was no significant association with RA in genotype distribution and allele frequency between RA female patients and controls (Table 3) .
Associations between GnRH1 Polymorphisms and parameters of disease activity
As phenotyping stratification, association between polymorphisms Patients with bone erosion (n) 73 (Table 6 ).
Associations between GnRH1 Haplotypes and ESR parameter in disease activity
Three among 5 SNPs formed LD block. Haplotypes (frequency＞ 0.01) in the LD block were analyzed using HapAnalyzer software 1.0.
18)
Four haplotype were shown. On the haplotype association test, haplotypes, CAG and TGG, showed a significant association between the ESR＜30 and ESR 30 RA patients, respectively (Table 7) .
Discussion
RA is a common autoimmune disease with a complex etiology in which genetic and environmental factors contribute to disease.
The genetic component of RA is largely undefined and, up until very recently, there were only two reproducible associations. The strongest of these associations is of genes within the HLA region, particularly the HLA-DRB1 gene. 19) A second, more mo dest, association identified has been of the protein tyrosine phosphatase non-receptor 22 (PTPN22) gene. 20, 21) In this study, we demonstrated that whether GnRH1 gene polymorphisms are associated with RA.
There was no association between RA susceptibility and GnRH1 in female population.
Altogether the genetics of RA susceptibility has made enormous progress during the past years. In contrast, the field of the genetics of RA severity is relatively unexplored. Radiological joint damage is conceived as the most objective measure to determine the severity of RA. The number of studies investigating the relation between joint destruction and genetic variants is limited. Some SNPs are observed to associate with the disease outcome, but none of these associations are convincingly replicated in independent cohorts.
Moreover, although a recent twin study indicated that genetic factors play a role in determining the severity of RA, 22) the heritability of the level of joint destruction (the variance of joint destruction that can be ascribed to genetic factors) is still unknown.
Joint damage in RA is highly variable between patients and the cumulative level is associated with the level of (persistent) inflammation. Nonetheless, several studies have provided evidence for 
Summary
In summary, the present study suggests that GnRH1 polymorphisms might not be associated with susceptibility to RA in female population. However, this study suggests that GnR1 gene polymorphisms may play a relevant role in the susceptibility to severity of ESR level in female RA patients. Additional studies, with a larger number of patients and in different populations, may be required to assess whether GnRH1 polymorphisms and these haplotype could be used as susceptibility or resistance markers in RA disease. This study is the first to analyze the association between SNPs of GnRH1 and RA, and may contribute to future studies on GnRH1. 
